Skip to main content
. 2019 Jan 19;8(2):e011206. doi: 10.1161/JAHA.118.011206

Table 3.

Crude Effect of Transcatheter Aortic Valve Replacement, Compared With Surgical Aortic Valve Replacement, on Hospital Complications, LOS, and Discharge Disposition in Hospitalizations of Octogenarians Undergoing Aortic Valve Replacement, Stratified by Charlson Comorbidity Index

CCI <2 OR (95% CI) CCI ≥2 OR (95% CI) P Valuea
In‐hospital complications
Permanent pacemaker implantation 1.72 (1.25, 2.38) 1.66 (1.23, 2.25) 0.88
Transient ischemic attack/stroke 0.89 (0.52, 1.52) 0.88 (0.57, 1.36) 0.97
Cardiogenic shock 0.57 (0.29, 1.11) 0.54 (0.35, 0.83) 0.88
Cardiac arrest 1.03 (0.60, 1.75) 1.68 (0.96, 2.96) 0.22
Acute kidney injury 0.58 (0.43, 0.80) 0.58 (0.48, 0.69) 0.96
Any bleeding 0.49 (0.40, 0.59) 0.42 (0.35, 0.50) 0.25
Blood transfusion 0.28 (0.23, 0.35) 0.37 (0.31, 0.44) 0.06
Vascular complications 1.24 (0.82, 1.88) 1.39 (0.95, 2.03) 0.68
Discharge disposition
Routine 2.41 (2.01, 2.91) 2.16 (1.83, 2.54) 0.35
Transfer, short‐term hospital 0.35 (0.13, 0.96) 0.81 (0.34, 1.92) 0.26
Transfer, skilled nursing facility 0.41 (0.34, 0.49) 0.45 (0.38, 0.53) 0.43
Death 1.14 (0.62, 2.10) 1.10 (0.69, 1.78) 0.94
CIE (95% CI) CIE (95% CI) P Valuea
LOS after AVR, days −2.61 (−2.99, −2.22) −3.56 (−4.09, −3.04) 0.004

AVR indicates aortic valve replacement; CCI, Charlson Comorbidity Index; CIE, change in estimate; LOS, length of stay; OR, odds ratio.

a

Testing the statistical significance of Charlson Comorbidity Index (<2 vs ≥2) as an interaction term for the association between TAVR and in‐hospital complication, discharge disposition, and LOS after AVR.